Psychometric Technologies
As innovative leaders in CRO, our proprietary technology and state-of-the-art-simulation drive our clinical studies.
Exclusive Proprietary Technology
CRC applies a broad range of proprietary technologies, including state-of-the-art simulation technologies in a broad range of studies with objectives that include:
- Assessing the therapeutic value of products developed to treat a wide range of disorders, particularly those that affect neuropsychiatric functioning;
- Assessing the effects of the full range of drugs and treatments for medical and psychiatric disorders on cognition, motoric abilities, wakefulness and mood; and
- Developing treatments and strategies to maintain and enhance cognitive performance diminished by age, fatigue, trauma or disease.
